JP2010518075A5 - - Google Patents

Download PDF

Info

Publication number
JP2010518075A5
JP2010518075A5 JP2009549052A JP2009549052A JP2010518075A5 JP 2010518075 A5 JP2010518075 A5 JP 2010518075A5 JP 2009549052 A JP2009549052 A JP 2009549052A JP 2009549052 A JP2009549052 A JP 2009549052A JP 2010518075 A5 JP2010518075 A5 JP 2010518075A5
Authority
JP
Japan
Prior art keywords
phosphate
composition
sodium phosphate
olopatadine
adjusting agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009549052A
Other languages
English (en)
Other versions
JP2010518075A (ja
JP5149308B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/003285 external-priority patent/WO2008097220A1/en
Publication of JP2010518075A publication Critical patent/JP2010518075A/ja
Publication of JP2010518075A5 publication Critical patent/JP2010518075A5/ja
Application granted granted Critical
Publication of JP5149308B2 publication Critical patent/JP5149308B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (2)

  1. a)オロパタジン遊離塩基0.54〜0.62%(w/v)または当量のオロパタジンの薬学的に許容できる塩;
    b)二塩基性リン酸ナトリウム0.2〜0.8%(w/v)と当量のリン酸塩であって、該リン酸塩は、一塩基性リン酸ナトリウム、二塩基性リン酸ナトリウム、三塩基性リン酸ナトリウム、一塩基性リン酸カリウム、二塩基性リン酸カリウム、および三塩基性リン酸カリウムからなる群から選択される、リン酸塩;
    c)NaCl 0.3〜0.6%(w/v);
    d)組成物がpH3.6〜3.8を有するのに十分な量のpH調節剤;
    e)塩化ベンザルコニウム0.005〜0.015%(w/v);
    f)エデト酸二ナトリウム0.005〜0.015%(w/v);ならびに
    g)水
    らなる、組成物。
  2. a)オロパタジン遊離塩基0.6%(w/v)または当量のオロパタジンの薬学的に許容できる塩;
    b)二塩基性リン酸ナトリウム0.4〜0.6%(w/v);
    c)NaCl 0.35〜0.45%(w/v);
    d)組成物がpH3.6〜3.8を有するのに十分な量のpH調節剤であって、該pH調節剤は、NaOHおよびHClからなる群から選択される、pH調節剤;
    e)塩化ベンザルコニウム0.01%(w/v);
    f)エデト酸二ナトリウム0.01%(w/v);ならびに
    g)水
    らなる、組成物。
JP2009549052A 2007-02-07 2007-02-07 局所的鼻腔投与のためのオロパタジンの製剤 Active JP5149308B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2007/003285 WO2008097220A1 (en) 2007-02-07 2007-02-07 Olopatadine formulations for topical nasal administration

Publications (3)

Publication Number Publication Date
JP2010518075A JP2010518075A (ja) 2010-05-27
JP2010518075A5 true JP2010518075A5 (ja) 2011-03-10
JP5149308B2 JP5149308B2 (ja) 2013-02-20

Family

ID=38542957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009549052A Active JP5149308B2 (ja) 2007-02-07 2007-02-07 局所的鼻腔投与のためのオロパタジンの製剤

Country Status (16)

Country Link
EP (2) EP2114367B1 (ja)
JP (1) JP5149308B2 (ja)
KR (1) KR20100014858A (ja)
CN (1) CN101621989A (ja)
AU (1) AU2007346121B2 (ja)
BR (1) BRPI0721255B8 (ja)
CA (1) CA2677631C (ja)
DK (1) DK2114367T3 (ja)
ES (2) ES2557939T3 (ja)
HK (1) HK1217090A1 (ja)
HU (1) HUE026162T2 (ja)
MX (1) MX2009008548A (ja)
PL (1) PL2114367T3 (ja)
PT (1) PT2114367E (ja)
SI (1) SI2114367T1 (ja)
WO (1) WO2008097220A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
EP2453872B1 (en) * 2009-07-17 2013-08-21 Alcon Research, Ltd. Olopatadine nasal spray regimen for children
KR101271925B1 (ko) * 2011-02-10 2013-06-05 비. 김 로버트 미네랄 알칼리수
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
CN103830219A (zh) * 2012-11-20 2014-06-04 深圳大佛药业有限公司 一种稳定的奥洛他定组合物
TW202133861A (zh) * 2019-12-06 2021-09-16 日商東興藥品工業股份有限公司 含有歐羅派特錠的點鼻用組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JP3662944B2 (ja) * 1993-08-24 2005-06-22 協和醗酵工業株式会社 点鼻剤
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
MXPA05005044A (es) * 2002-11-12 2005-07-01 Alcon Inc El uso de un agente antialergico y un esteroide para tratar rinitis alergica.
ATE443516T1 (de) 2004-11-24 2009-10-15 Alcon Inc Verfahren zur verabreichung eines nasensprays

Similar Documents

Publication Publication Date Title
JP2010518075A5 (ja)
JP2006526031A5 (ja)
JP2009503045A5 (ja)
EP2397476A3 (en) Indole derivative having PGD2 receptor antagonist activity
JP2010529999A5 (ja)
JP2008520565A5 (ja)
JP2010500331A5 (ja)
JP2008522981A5 (ja)
JP2008516004A5 (ja)
GB0614353D0 (en) Oral compositions, their preparation and use
JP2008513510A5 (ja)
JP2008520662A5 (ja)
JP2012533554A5 (ja)
JP2009538276A5 (ja)
HRP20130946T1 (hr) Olopatadin nazalni sprej, namijenjen upotrebi kod djece
JP2009518415A5 (ja)
JP2015523546A5 (ja)
IL174830A0 (en) Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation
JP2008517059A5 (ja)
JP2004532828A5 (ja)
HRP20110023T1 (hr) Smanjenje prekomjerne težine ili pretilosti
JP2006510607A5 (ja)
JP2009543804A5 (ja)
JP2007145708A5 (ja)
JP2009067947A5 (ja)